Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 10:55 PM
NCT ID:
NCT01802567
Group ID:
EG000
Title:
Guided Therapy- Pediatric Gene Analysis Platform
Description:
A total of 48 pediatric cancer (neuroblastoma, brain tumor, and rare tumor) patients who are refractory or relapsed on conventional therapy will be treated. Guided therapy will allow the use of any therapeutic combination (up to 4 agents) provided it includes medications contained in the study report. All patients will be followed for survival, disease response, progression and safety. All patients will be treated according to the discretion of the treating oncologist and study committee (minimum 3 oncologists and one pharmacist). Extent of disease will be measured and assessed for changes throughout the course of the study and at 6-8 week intervals (every 2 cycles).
Adverse events were reported as a whole for all subjects that started study therapy and were not reported by individual cohort.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
45
Other Number Affected:
43
Other Number At Risk:
45
Study:
NCT01802567
Results Section:
NCT01802567
Adverse Events Module:
NCT01802567